Skip to main content
Clinical Trials/EUCTR2010-019691-70-BE
EUCTR2010-019691-70-BE
Active, not recruiting
Phase 1

Pharmacokinetic evaluation of fluoroquinolone antibiotics administered intravenously in intensive care patients with normal renal function and with renal hyperfiltration

Ghent University0 sitesApril 7, 2010

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Intensive care patients
Sponsor
Ghent University
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2010
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients hospitalized at the Department Intensive Care Unit who are being treated with Tavanic I.V. (500mg, twice daily) for an infection.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Younger than 18 years
  • No informed consent
  • No arterial catheter
  • Hematocrite \= 21
  • Pregnancy and lactation
  • Creatinine clearance \< 80 ml/min

Outcomes

Primary Outcomes

Not specified

Similar Trials